Skip to main content

Biomarin Pharmaceuticals(BMRN-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

BioMarin to Present Innovative Pipeline at R&D Day on September 12th in New York

PR Newswire - Mon Sep 11, 2023

Live Audio Webcast to Begin at 8:00 a.m. Eastern Time

SAN RAFAEL, Calif., Sept. 11, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, will update the investor community on the company's research and development portfolio, including early-stage product candidates and new indication opportunities with VOXZOGO and ROCTAVIAN. In addition, external clinicians from leading global institutions will participate in panel discussions.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe